The effect of omega-3 and zinc in the treatment of diabetes

Phase 3

• Conditions: Type 2 diabetes.; Diabetes mellitus; E10, E11,

• Registration Number: IRCT20170214032571N2
• Lead Sponsor: rmia University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

tendency to Cooperation
Type 2 diabetic patients ; taking metformin or glibenclamide glucose or similar drugs by patients
Age range 18 to 65 years
use of lipid lowering statin drugs and a blood pressure lowering drugs

Exclusion Criteria

Unwillingness to participate in the study
Insulin injection
Do not consume 80% of supplements per course
People with pancreatic cancer and patients receiving steroidal anti-inflammatory drugs (due to secondary hyperglycemia)
severe physical activity
Use of omega-3 and zinc supplementation in the last three months
developing any underlying coronary artery disease and cancer
taking antidepressants (because of interactions with zinc supplementation)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total cholesterol. Timepoint: Before intervention and two months after intervention. Method of measurement: Enzymatic method, mg / dl.;TAC. Timepoint: Before intervention and two months after intervention. Method of measurement: Colorimetric.;Hs-crp. Timepoint: Before intervention and two months after intervention. Method of measurement: Eliza-mg/dl.;HDL. Timepoint: Before intervention and two months after intervention. Method of measurement: Enzymatic method, mg / dl.;Tri glyceride ??. Timepoint: Before intervention and two months after intervention. Method of measurement: Enzymatic method, mg / dl.;LDL. Timepoint: Before intervention and two months after intervention. Method of measurement: Enzymatic method, mg / dl.